New partnership to prioritise mesothelioma treatment uncertainties

Today is the launch of an important ‘Priority Setting Partnership’ (PSP) set up by the James Lind Alliance (JLA) to identify and prioritise unanswered questions about mesothelioma treatments. Mesothelioma is a rare and often fatal form of cancer with very poor survival rates. It is most commonly caused by breathing in asbestos dust. Mesothelioma usually...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news